Anti-SLC24A5 monoclonal antibody

Pre-made anti-SLC24A5 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC24A5/SLC24A5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1666-Ab-1/ GM-Tg-hg-IP1666-Ab-2Anti-Human SLC24A5 monoclonal antibodyHuman
GM-Tg-rg-IP1666-Ab-1/ GM-Tg-rg-IP1666-Ab-2Anti-Rat SLC24A5 monoclonal antibodyRat
GM-Tg-mg-IP1666-Ab-1/ GM-Tg-mg-IP1666-Ab-2Anti-Mouse SLC24A5 monoclonal antibodyMouse
GM-Tg-cynog-IP1666-Ab-1/ GM-Tg-cynog-IP1666-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC24A5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1666-Ab-1/ GM-Tg-felg-IP1666-Ab-2Anti-Feline SLC24A5 monoclonal antibodyFeline
GM-Tg-cang-IP1666-Ab-1/ GM-Tg-cang-IP1666-Ab-2Anti-Canine SLC24A5 monoclonal antibodyCanine
GM-Tg-bovg-IP1666-Ab-1/ GM-Tg-bovg-IP1666-Ab-2Anti-Bovine SLC24A5 monoclonal antibodyBovine
GM-Tg-equg-IP1666-Ab-1/ GM-Tg-equg-IP1666-Ab-2Anti-Equine SLC24A5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1666-Ab-1/ GM-Tg-hg-IP1666-Ab-2; GM-Tg-rg-IP1666-Ab-1/ GM-Tg-rg-IP1666-Ab-2;
GM-Tg-mg-IP1666-Ab-1/ GM-Tg-mg-IP1666-Ab-2; GM-Tg-cynog-IP1666-Ab-1/ GM-Tg-cynog-IP1666-Ab-2;
GM-Tg-felg-IP1666-Ab-1/ GM-Tg-felg-IP1666-Ab-2; GM-Tg-cang-IP1666-Ab-1/ GM-Tg-cang-IP1666-Ab-2;
GM-Tg-bovg-IP1666-Ab-1/ GM-Tg-bovg-IP1666-Ab-2; GM-Tg-equg-IP1666-Ab-1/ GM-Tg-equg-IP1666-Ab-2
Products NameAnti-SLC24A5 monoclonal antibody
Formatmab
Target NameSLC24A5
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC24A5 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1666-Ag-1Recombinant multi-species NCKX5/ SLC24A5/ JSX protein


    Target information

    Target IDGM-IP1666
    Target NameSLC24A5
    Gene ID283652,317750,311387,714236,612878,101085380,781411
    Gene Symbol and SynonymsF630045L20Rik,JSX,NCKX5,NCX5,OCA6,SHEP4,SLC24A5
    Uniprot AccessionQ71RS6
    Uniprot Entry NameNCKX5_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000188467
    Target ClassificationN/A

    The target: SLC24A5, gene name: SLC24A5, also named as JSX, NCKX5, OCA6, SHEP4. This gene is a member of the potassium-dependent sodium/calcium exchanger family and encodes an intracellular membrane protein with 2 large hydrophilic loops and 2 sets of multiple transmembrane-spanning segments. Sequence variation in this gene has been associated with differences in skin pigmentation. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.